Amlodipine Besylate and Olmesartan Medoxomil
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Amlodipine Besylate and Olmesartan Medoxomil, covering 2016-10-28 to 2023-06-23. Get the full timeline:
Most recent: FDA Approved: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Ajanta Pharma USA Inc.)